[1]
|
Maron, B., Rowin, E. and Maron, M. (2018) Global Burden of Hypertrophic Cardiomyopathy. JACC: Heart Failure, 6, 376-378. https://doi.org/10.1016/j.jchf.2018.03.004
|
[2]
|
Du, Y., Wang, Y., Han, X., Feng, Z. and Ma, A. (2019) MYH7 Gene-Related Mutation P.V878l Identified in a Chinese Family with Hypertrophic Cardiomyopathy. Internation-al Heart Journal, 60, 1415-1420.
https://doi.org/10.1536/ihj.19-146
|
[3]
|
Coats, C. and Elliott, P. (2013) Genetic Biomarkers in Hypertrophic Car-diomyopathy. Biomarkers in Medicine, 7, 505-516. https://doi.org/10.2217/bmm.13.79
|
[4]
|
Arimura, T., Hayashi, T. and Kimura, A. (2007) Molecular Etiology of Idiopathic Cardiomyopathy. Acta Myologica, 26, 153-158.
|
[5]
|
Wang, H., Lin, Y., Zhang, R., Chen, Y., Ji, W., Li, S., et al. (2022) Viaprogrammed Exercise Attenuates Familial Hypertrophic Cardiomyopathy in Transgenic E22k Mice Inhibition of Pkc-Α/Nfat Pathway. Frontiers in Cardiovascular Medicine, 9, Article ID: 808163. https://doi.org/10.3389/fcvm.2022.808163
|
[6]
|
Teare, D. (1958) Asymmetrical Hypertrophy of the Heart in Young Adults. Heart, 20, 1-8.
https://doi.org/10.1136/hrt.20.1.1
|
[7]
|
Maron, B., Maron, M. and Semsarian, C. (2012) Genetics of Hypertrophic Cardiomyopathy after 20 Years: Clinical Perspectives. Journal of the American College of Cardiology, 60, 705-715. https://doi.org/10.1016/j.jacc.2012.02.068
|
[8]
|
Maron, B. and Maron, M. (2016) The Remarkable 50 Years of Imaging in HCM and How It Has Changed Diagnosis and Management: From M-Mode Echocardiography to CMR. JACC: Cardiovascular Imaging, 9, 858-872.
https://doi.org/10.1016/j.jcmg.2016.05.003
|
[9]
|
Ackerman, M., Priori, S., Willems, S., Berul, C., Brugada, R., Calkins, H., et al. (2011) HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopa-thies and Cardiomyopathies This Document Was Developed as a Partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). EP Europace, 8, 1077-1109. https://doi.org/10.1093/europace/eur245
|
[10]
|
Wang, B., Wang, J., Wang, L., Yang, F., Xu, L., Li, W.X., et al. (2019) Genetic Analysis of Monoallelic Double MYH7 Mutations Responsible for Familial Hypertrophic Cardiomyopa-thy. Molecular Medicine Reports, 20, 5229-5238.
https://doi.org/10.3892/mmr.2019.10754
|
[11]
|
吴桂鑫, 邹玉宝, 康连鸣, 惠汝太, 宋雷, 许连军. 《2020年AHA/ACC肥厚型心肌病诊断及治疗指南》解读[J]. 中国分子心脏病学杂志, 2020, 20(6): 3594-3597.
|
[12]
|
Geske, J., Ommen, S. and Gersh, B. (2018) Hypertrophic Cardiomyopathy: Clinical Update. JACC: Heart Failure, 6, 364-375. https://doi.org/10.1016/j.jchf.2018.02.010
|
[13]
|
The 1000 Genomes Project Consortium (2015) A Global Reference for Human Genetic Variation. Nature, 526, 68-74.
https://doi.org/10.1038/nature15393
|
[14]
|
Lek, M., Karczewski, K., Minikel, E., Samocha, K.E., Banks, E., Fennell, T., et al. (2016) Analysis of Protein-Coding Genetic Variation in 60,706 Humans. Nature, 536, 285-291. https://doi.org/10.1038/nature19057
|
[15]
|
Homburger, J., Green, E., Caleshu, C., Sunitha, M.S., Taylor, R.E., Ruppel, K.M., et al. (2016) Multidimensional Structure-Function Relationships in Human β-Cardiac Myosin from Popu-lation-Scale Genetic Variation. Proceedings of the National Academy of Sciences of the United States of America, 113, 6701-6706.
https://doi.org/10.1073/pnas.1606950113
|
[16]
|
Lee, S., Ashley, E., Homburger, J., Caleshu, C., Green, E.M., Jacoby, D., et al. (2018) Incident Atrial Fibrillation Is Associated with MYH7 Sarcomeric Gene Variation in Hyper-trophic Cardiomyopathy. Circulation: Heart Failure, 11, Article ID: e005191. https://doi.org/10.1161/CIRCHEARTFAILURE.118.005191
|
[17]
|
Mattivi, C., Bos, J., Bagnall, R., Nowak, N., Giudicessi, J.R., Ommen, S.R., et al. (2020) Clinical Utility of a Phenotype-Enhanced MYH7-Specific Variant Classifi-cation Framework in Hypertrophic Cardiomyopathy Genetic Testing. Circulation: Genomic and Precision Medicine, 13, 453-459. https://doi.org/10.1161/CIRCGEN.120.003039
|
[18]
|
Marian, A. and Braunwald, E. (2017) Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. Circulation Research, 121, 749-770. https://doi.org/10.1161/CIRCRESAHA.117.311059
|
[19]
|
Marian, A. (2021) Molecular Genetic Basis of Hypertrophic Cardiomyopathy. Circulation Research, 128, 1533-1553.
https://doi.org/10.1161/CIRCRESAHA.121.318346
|
[20]
|
Kimura, A., Ito-Satoh, M., Hayashi, T., Takahashi, M. and Arimura, T. (2001) Molecular Etiology of Idiopathic Cardiomyopathy in Asian Populations. Journal of Cardiology, 37, 139-146.
|
[21]
|
Kimura, A. (2010) Molecular Basis of Hereditary Cardiomyopathy: Abnormalities in Calcium Sensi-tivity, Stretch Response, Stress Response and beyond. Journal of Human Genetics, 55, 81-90. https://doi.org/10.1038/jhg.2009.138
|
[22]
|
钟海雷, 李妍伸, 杜彬彬, 邢清和, 贺林, 张彦周. 中国一肥厚型梗阻性心肌病家系MYH7基因Arg143Gln突变研究[J]. 中国优生优育, 2014, 20(3): 137-140.
|
[23]
|
邵春丽. 肥厚型心肌病的梗阻机制及基因型——表型的关联研究[D]: [博士学位论文]. 北京: 清华大学医学部, 2010.
|
[24]
|
Sedaghat-Hamedani, F., Kayvanpour, E., Tugrul, O., Lai, A., Amr, A., Haas, J., et al. (2018) Clinical Out-comes Associated with Sarcomere Mutations in Hypertrophic Cardiomyopathy: A Meta-Analysis on 7675 Individuals. Clinical Research in Cardiology, 107, 30-41. https://doi.org/10.1007/s00392-017-1155-5
|
[25]
|
Viswanathan, S., Sanders, H., Mcnamara, J., Jagadeesan, A., Jahangir, A., Tajik, A.J., et al. (2017) Hypertrophic Cardiomyopathy Clinical Phenotype Is Independent of Gene Mutation and Mutation Dosage. PLOS ONE, 12, Article ID: e0187948. https://doi.org/10.1371/journal.pone.0187948
|